Overall reductions in the individual parameters of the metabolic syndrome subjects were significantly higher in Group I. Cholesterol level decreased from @ % to @ % ( P < @ ) , triglyceride levels decreased from @ % to @ % , VLDL and LDL levels reduced by @ % & @ % respectively after @ months of therapy .